Centrala Farmaceutyczna CefarmS.A.Active

The main business activity of Centrala Farmaceutyczna Cefarm focuses on wholesale of pharmaceutical goods.

The company was registered in the Polish National Court Register (KRS) on March 13, 2003.

The headquarters is located at: Jana Kazimierza 16, 01-248 Warszawa.

The management board consists of: Grzegorz Ornowski (President of the Management Board).

The share capital of the company is PLN 55,400,000 (approx. $15 million).

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

In 2023, the company generated total revenue of $349,390,561, representing an increase of 14.4% compared to 2022.

Yes, in 2023 the company was profitable, achieving a net profit of $2,541,409, meaning the company increased its profit by 105.4%.

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $329,614,320 in 2023, representing 95% of all operating expenses.